Photo:
shformacion.es
Apr 19, 2026, 13:52
David Montani: SOX17 Variants and Their Broader Impact in Pulmonary Arterial Hypertension
David Montani, Professor of Pulmonology and Hospital Practitioner at Paris-Saclay University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in International Journal of Cardiology:
“Happy to share this editorial, written with Thomas Lacoste-Palasset, Julien Grynblat, Grégoire Ruffenach, and Florence Coulet: ‘SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype’.”
Title: SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype
Authors: Thomas Lacoste-Palasset, Julien Grynblat, Gregoire Ruffenach, Florence Coulet, David Montani
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 12:53Masoabi Sefojane: In Africa 88% of Hemophilia Remains Undiagnosed
-
May 6, 2026, 12:36Alan Nurden: CRISPR-Mediated Megakaryocyte Modeling in Glanzmann Thrombasthenia
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?